Biography

CV

Cecilia Fosser works as a Principal Statistician within the Full Service Provider division of Ctyel supporting clinical drug development. Previously she led the Quantitative Pharmacology and Pharmacometrics group within Strategic Consulting at Cytel. She got her Ph.D. in applied mathematics from The University of Arizona while on a national fellowship. There she focused on modeling and simulation of systems of nonlinear differential equations. She worked as a clinical statistician and pharmacometrician at Pfizer for over 10 years: four years on early and late phase clinical research projects as a statistician, followed by six years with Pfizer’s pharmacometrics group providing modeling and simulation of clinical trial data across many therapeutic areas with a focus on inflammation. In July of 2014, Cecilia joined Cytel Inc. to work in a hybrid position where she combines statistical and pharmacometrics techniques for quantitative drug development.

Cecilia has presented at several large international conferences (ASCPT, and ACoP), worked and published on exposure-response analyses of multiple endpoints, and in particular on multivariate Cox proportional hazards modeling of clinical risk factors for safety and efficacy endpoints. She has provided comparative effectiveness analysis in the form of model-based meta-analysis of psoriasis treatments, as well as, for chronic kidney disease endpoints and treatments. As both a statistician and a pharmacometrician Cecilia provides industry-leading approaches, including advanced modeling and simulation techniques, that contribute to quantitative decision making.